Clinical Trial Update: Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on re-induction therapy for relapsed pediatric T-cell acute lymphoblastic leukemia or lymphoma; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Leukemia B-cell
• Leukemia T-cell
• Lymphoma Non-hodgkin

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Lymphoblastic Leukemia, Lymphoma, Non-Hodgkin's | Phase 2 | Status: TERMINATED | Results posted: 2019-04-03